BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38178572)

  • 1. Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.
    Yousuf S; Busch D; Renner R; Schliep S; Erfurt-Berge C
    Ren Fail; 2024 Dec; 46(1):2297566. PubMed ID: 38178572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.
    Colboc H; Moguelet P; Bazin D; Carvalho P; Dillies AS; Chaby G; Maillard H; Kottler D; Goujon E; Jurus C; Panaye M; Frochot V; Letavernier E; Daudon M; Lucas I; Weil R; Courville P; Monfort JB; Chasset F; Senet P;
    JAMA Dermatol; 2019 Jul; 155(7):789-796. PubMed ID: 31116362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
    Brandenburg VM; Kramann R; Rothe H; Kaesler N; Korbiel J; Specht P; Schmitz S; Krüger T; Floege J; Ketteler M
    Nephrol Dial Transplant; 2017 Jan; 32(1):126-132. PubMed ID: 26908770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
    Gaisne R; Péré M; Menoyo V; Hourmant M; Larmet-Burgeot D
    BMC Nephrol; 2020 Feb; 21(1):63. PubMed ID: 32101140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy.
    Santos PW; He J; Tuffaha A; Wetmore JB
    Int Urol Nephrol; 2017 Dec; 49(12):2247-2256. PubMed ID: 29058165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcific uremic arteriolopathy: a call for action.
    Brandenburg VM; Cozzolino M; Mazzaferro S
    Semin Nephrol; 2014 Nov; 34(6):641-7. PubMed ID: 25498382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
    Floege J; Kubo Y; Floege A; Chertow GM; Parfrey PS
    Clin J Am Soc Nephrol; 2015 May; 10(5):800-7. PubMed ID: 25887067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calciphylaxis after parathyroidectomy.
    Karmegam S; Shetty A
    Hemodial Int; 2017 Oct; 21 Suppl 2():S62-S66. PubMed ID: 29064176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calciphylaxis: Beyond CKD-MBD.
    Fernández M; Morales E; Gutierrez E; Polanco N; Hernández E; Mérida E; Praga M
    Nefrologia; 2017; 37(5):501-507. PubMed ID: 28390776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left atrial appendage occlusion as replacement of coumarin anticoagulants in calciphylaxis].
    Andolfatto M; Tangredi M; Vischi M; Pinerolo C; Cereda A; Napodano P; Cozzolino M
    G Ital Nefrol; 2022 Jun; 39(3):. PubMed ID: 35819038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penile calcific uremic arteriolopathy occurring postparathyroidectomy in a hemodialysis patient.
    Bashir SO; Aamer MA; Omer HA; Morsy MD
    Saudi J Kidney Dis Transpl; 2016; 27(6):1265-1269. PubMed ID: 27900978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calciphylaxis: Controversies in Pathogenesis, Diagnosis and Treatment.
    Jeong HS; Dominguez AR
    Am J Med Sci; 2016 Feb; 351(2):217-27. PubMed ID: 26897281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calciphylaxis: from the disease to the diseased.
    Oliveira TM; Frazão JM
    J Nephrol; 2015 Oct; 28(5):531-40. PubMed ID: 25835730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Cutaneous Calciphylaxis.
    Kodumudi V; Jeha GM; Mydlo N; Kaye AD
    Adv Ther; 2020 Dec; 37(12):4797-4807. PubMed ID: 32997277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcific uremic arteriolopathy (calciphylaxis)].
    Gauthey D; Morisod J; Coutaz M
    Rev Med Suisse; 2008 May; 4(156):1167-71. PubMed ID: 18630172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
    Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
    Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calciphylaxis: a rare complication in alcoholic liver disease.
    Sermijn E; Strobbe T; Vandekerckhove L; Libbrecht L; Colle I; Schoonjans R; Vogelaers D
    Acta Clin Belg; 2013; 68(2):116-9. PubMed ID: 23967720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment.
    Chiriac A; Grosu OM; Terinte C; Perţea M
    J Dermatolog Treat; 2020 Aug; 31(5):545-548. PubMed ID: 31075991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calciphylaxis].
    Brandenburg VM; Martin H; Sohn CM; Ketteler M
    Dtsch Med Wochenschr; 2015 Mar; 140(5):347-51. PubMed ID: 25734678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis.
    Ruderman I; Toussaint ND; Hawley CM; Krishnasamy R; Pedagogos E; Lioufas N; Elder GJ
    Nephrol Dial Transplant; 2021 Mar; 36(4):649-656. PubMed ID: 31855262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.